Subscribe free

Cytoreductive Surgery & Peritoneum ·

High risk of venous thromboembolism in peritoneal mesothelioma patients highlights need for vigilant monitoring

Peritoneal mesothelioma patients had a high venous thromboembolism (VTE) risk, with 21.7% experiencing VTE, mainly symptomatic pulmonary emboli. 4-week thromboprophylaxis post-surgery resulted in acceptable 90-day VTE rates. Surgical patients and those with low serum albumin had higher VTE risk, but overall survival did not significantly differ between patients with and without VTE. These findings underscore the importance of ongoing VTE surveillance in peritoneal mesothelioma patients.

Journal Article by Bansal VV, Mitchell O (…) Turaga KK et 11 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →